Chemotherapy for Patients With Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and toxicity of pemetrexed dosing that is
tailored to individual patient tolerance in patients with advanced non-small cell lung cancer
(NSCLC).